Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
An award-wining organic snack and baking company focusing on allergy-free foods that only contain natural sugars and are suitable for vegans. Creative Nature's products are available in more than 3,500 stores in the UK, as well as online and worldwide in 11 countries. Over the next 12 months, the business intends to provide an online subscription model to generate greater website revenue and to increase production across their product range.
days to go:
Expired
investment:
£503,232
nHouse supplies modular method eco-friendly homes and by building homes in controlled factory enviroments, each module is defect-free before being transported to the site for assembly, resulting in cost saving and increase customizability. Their homes boast energy efficiency with A rating at EPC, resulting in minimized energy costs for occupants and redice carbon emissions.
days to go:
Expired
investment:
£183,839
Using artificial intelligence to accurately match a person's CV with a business's job requirements. Recruitment Smart have developed SniperAI, a tool created by specialists and a researcher from Carnegie Mellon University to quickly search and scan the ideal candidate for a specific job role.
This technology can be integrated into a company's job listings to automatically screen submitted CVs and returns a suitability score. In addition, as HR departments are under constant scrutiny to provide information on equality in the workplace, SniperAI can offer a list of appropriate candidates without bias. Recruitment Smart will generate revenue from initial set-up costs and licensing the product to businesses.
days to go:
Expired
investment:
£272,650
Equal Health's (EH) mission is to create a healthy organic food brand that makes a difference to the environment and its customers' health. The company wants to become the go-to brand for healthy organic meals. EH uses seasonal organic ingredients which are ethically sourced, cooked and packed in its kitchen by its expert team of chefs. It received its organic status through the UK's leading certification body, The Soil Association. It aims to launch a new range of healthy organic frozen meals. EH will use the investment to focus on digital marketing, increase its kitchen facilities, and invest in New Product Development (NPD).
days to go:
Expired
investment:
£226,598
WeSwap is an award-winning P2P travel money platform that enables travellers around the globe to exchange currency in a hassle-free and transparent manner. The company has over 500,000 users who have swapped and spent more than £255 million in 197 countries and territories. WeSwap has also launched a portfolio of travel money products such as travel cash and buyback. The company has also garnered over 3000 reviews and earned a five-star rating on Trustpilot. Furthermore, WeSwap has won "Best Travel Money Provider" title for two consecutive years at the British Bank Awards. With the proceeds, the company will launch in international markets, make new products and develop new partnerships.
days to go:
Expired
investment:
£2,520,786
